The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Independent Analysis of Permian Well results

17 Feb 2010 07:41

RNS Number : 2644H
ViaLogy PLC
17 February 2010
 



VIALOGY PLC

 

INDEPENDENT ANALYSIS VERIFIES VIALOGY

PERMIAN WELL PREDICTIONS

 

London, February 17. ViaLogy (LSE:VIY) announces the start of oil production from a recently completed successful well in the Strawn formation in Texas, and independent confirmation of ViaLogy's reservoir attribute predictions. The client specified that ViaLogy find Strawn with significant thickness to make a commercially successful well; that major zones of porosity over 4% be identified; and that the selected Strawn section exhibit natural fracturing to enable optimal production.

Final well and formation micro-imaging (FMI) logs, done by Halliburton, show that QuantumRD directly detected and predicted a 220 foot continuous Strawn section. Within this section, ViaLogy's pre-drilling analysis located high porosity limestone zones - totaling over 80 feet with more than 4% porosity. Logging showed a continuous zone of 50 feet with greater than 6% porosity, and reaching 10 to 12%. The ability of the technology to find and distinguish between such small variations in limestone porosity demonstrates QuantumRD's sensitivity, and its utility in mapping the Strawn and other formations where porosity is a critical factor in determining a well's economic viability. In addition, the analysis also verified that QuantumRD located natural fractures enhancing the reservoir's permeability and enabling extraction to be optimized. ViaLogy's contract prohibits identifying the client.

This ViaLogy-positioned well is in the Permian Basin, one of the largest structural basins and most prolific petroleum provinces in North America, extending approximately 86,000 sq miles over Texas and New Mexico. It sits in the naturally fractured Spraberry Trend Area in west Texas covering approximately 2,500 square miles over a six county area. Estimated to hold 6-10 billion bbls of oil, this trend area has huge potential for future recovery as only about 700 million bbls have been produced over the past 50 years. This is due in part to the analytical challenges of finding high porosities and developing economically viable wells in the carbonate, limestone and/or dolomite platform, and to natural fractures in a rock matrix with inherently low permeability. Also, unlike conventional faulted sandstone reservoirs, the Permian platform is a stratigraphic formation with discontinuities over small areas. Current exploration technologies and basin geology models provide limited insight for positioning individual wells and offsets, as the formation properties change unpredictably due to complex cementation and matrix dissolution processes. QuantumRD's more innovative computational approach to characterize the subsurface and locate drilling targets should assist in the Permian Basin's exploitation.

Robert Dean, ViaLogy CEO, said, "Independent confirmation of QuantumRD's Strawn success further validates the technology's power. ViaLogy's work is done on the basis of specific client drilling requirements - they tell us what quantifiable characteristics to find, such as porosity, and this can vary depending upon the location, formation characteristics and land area where a client wants to drill. We offer an 'energy solution' - the ability to identify drilling sites, depths, porosities and trends based on a synergistic integration of rock physics, 3-D and multi-component seismic data, and depositional geology. In this well we used QuantumRD, our proprietary weak signal detection technology, to locate regions of high porosity within a range of carbonate sizes that are key for positioning successful Permian wells."

He added, "Our technology can be applied to virtually any hydrocarbon formation, and we have a growing customer list and backlog that will take us into other areas of the Permian and other completely different areas. We are now finalizing our next drilling recommendation location on this particular Strawn prospect, and we intend to deliver another success to our client. We are also in discussions with several exploration & production firms to deliver QuantumRD analysis on the Permian."

 

ViaLogy PLC

 

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

 

 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy +44 (0) 20-7107-8000

 

 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com.

 

 

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results,

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLDDLBFBLFXBBK
Date   Source Headline
7th Feb 20177:00 amRNSSouthern Europe Business Update
10th Jan 20173:33 pmRNSResult of General Meeting
10th Jan 20177:15 amRNSHardman Research: Yourgene improves growth
21st Dec 20164:00 pmRNSPosting of Circular
21st Dec 20167:00 amRNSHalf year results
21st Dec 20167:00 amRNSConditional Acquisition of Yourgene Bioscience
21st Nov 20167:00 amRNSPremaitha establishes first service lab in Asia
31st Oct 20167:00 amRNSPremaitha welcomes UK Govt. decision on NIPT
27th Oct 20164:10 pmRNSResult of AGM
27th Oct 20167:00 amRNSAGM Statement
21st Oct 20167:00 amRNSGrant of Options
3rd Oct 20167:15 amRNSHardman Research: Excellent first year for IONA®
30th Sep 20163:38 pmRNSNotice of AGM
30th Sep 20167:00 amRNSFinal Results
23rd Sep 201610:42 amRNSHolding(s) in Company
23rd Sep 20168:50 amRNSNotice of results & appointment of broker
23rd Sep 20168:50 amRNSInvestment agreement extension with Thermo Fisher
8th Sep 20169:08 amRNSDirectorate Change
6th Jul 20167:00 amRNSDirectorate Change
4th Jul 20167:00 amRNSProgress on anti-trust objections to litigation
22nd Jun 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
22nd Apr 201610:45 amRNSUpdate on competitor patent litigation
20th Apr 201611:14 amRNSHardman Research: IONA sales & litigation update
20th Apr 20167:00 amRNSPatent Litigation Rescheduled
18th Apr 20161:13 pmRNSHardman & Co Issues Research Report
18th Apr 20161:03 pmRNSHardman & Co Issues Research Report
14th Apr 20167:00 amRNSHolding(s) in Company
13th Apr 20169:52 amRNSHolding(s) in Company
13th Apr 20167:00 amRNSHoldings in Company, Director's Shareholding
11th Apr 20167:00 amRNSTrading Update
29th Mar 20167:00 amRNSPremaitha announces tenth customer laboratory
21st Mar 20167:00 amRNSDistribution Agreements in the Middle East
9th Mar 20165:21 pmRNSHolding in Company, Directors' Dealing Replacement
9th Mar 20163:33 pmRNSHolding in Company, Directors' Dealings
9th Mar 20167:00 amRNSDistribution Agreement with GeNext - Russia
7th Mar 20167:00 amRNSAppointment of Joint Broker
3rd Feb 20167:00 amRNSPremaitha partners with Visional Medical in India
2nd Feb 20167:00 amRNSPremaitha partners with Leeds Hospitals NHS Trust
28th Jan 20167:00 amRNSHardman & Co Research Report: IONA®-Up and running
27th Jan 20167:00 amRNSTwo new customers signed for clinical lab service
26th Jan 20162:29 pmRNSUpdate on UK Litigation Timing
15th Jan 20167:00 amRNSPremaitha welcomes NSC recommendation on NIPT
8th Jan 201612:40 pmRNSUpdate on competitor patent litigation
18th Dec 20157:00 amRNSDirector/PDMR Shareholding
16th Dec 20155:53 pmRNSHolding(s) in Company
15th Dec 20157:00 amRNSHardman Issues Research Report
14th Dec 20157:00 amRNSInvestment Agreement with Thermo Fisher Scientific
14th Dec 20157:00 amRNSHalf Yearly Report
11th Dec 20157:00 amRNSNotice of Half Year Results
2nd Dec 20157:00 amRNSFirst IONA® testing service in France at LaboSud

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.